Skip to search.
 TSX Down 2.02% TSX Ventures Down 0.54%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
0.93 Down 0.01(1.06%) 3:55PM EST
Prev Close:0.94
Open:0.94
Bid:N/A
Ask:1.90 x 1500
1y Target Est:2.80
Beta:2.27132
Next Earnings Date:N/A
Day's Range:0.90 - 0.94
52wk Range:0.80 - 9.30
Volume:141,145
Avg Vol (3m):68,905
Market Cap:36.08M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback